Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,410.00p
   
  • Change Today:
    -50.00p
  • 52 Week High: 1,540.00
  • 52 Week Low: 736.00
  • Currency: UK Pounds
  • Shares Issued: 48.89m
  • Volume: 54,814
  • Market Cap: £689.35m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
61.21% above the market average61.21% above the market average61.21% above the market average61.21% above the market average61.21% above the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average
1yr Revenue Growth
68.82% above the market average68.82% above the market average68.82% above the market average68.82% above the market average68.82% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
15.26% above the market average15.26% above the market average15.26% above the market average15.26% above the market average15.26% above the market average
22.58% below the sector average22.58% below the sector average22.58% below the sector average22.58% below the sector average22.58% below the sector average
Price Book Ratio
88.23% below the market average88.23% below the market average88.23% below the market average88.23% below the market average88.23% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
74.09% above the market average74.09% above the market average74.09% above the market average74.09% above the market average74.09% above the market average
67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average
Price Chg 3m
73.11% above the market average73.11% above the market average73.11% above the market average73.11% above the market average73.11% above the market average
54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
56.71% above the market average56.71% above the market average56.71% above the market average56.71% above the market average56.71% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
Momentum 20
93.88% above the market average93.88% above the market average93.88% above the market average93.88% above the market average93.88% above the market average
90.00% above the sector average90.00% above the sector average90.00% above the sector average90.00% above the sector average90.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
34.37% above the market average34.37% above the market average34.37% above the market average34.37% above the market average34.37% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
ROCE
73.93% above the market average73.93% above the market average73.93% above the market average73.93% above the market average73.93% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
68.82% above the market average68.82% above the market average68.82% above the market average68.82% above the market average68.82% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Forecast EPS
33.44% above the market average33.44% above the market average33.44% above the market average33.44% above the market average33.44% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
25.38% above the market average25.38% above the market average25.38% above the market average25.38% above the market average25.38% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average
Operating Profit Loss
47.90% above the market average47.90% above the market average47.90% above the market average47.90% above the market average47.90% above the market average
64.00% above the sector average64.00% above the sector average64.00% above the sector average64.00% above the sector average64.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
19.13% above the market average19.13% above the market average19.13% above the market average19.13% above the market average19.13% above the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average
Cash
20.69% above the market average20.69% above the market average20.69% above the market average20.69% above the market average20.69% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
86.40% above the market average86.40% above the market average86.40% above the market average86.40% above the market average86.40% above the market average
88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
39.29% above the market average39.29% above the market average39.29% above the market average39.29% above the market average39.29% above the market average
3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 1,410.00p
Change Today -50.00p
% Change -3.42 %
52 Week High 1,540.00
52 Week Low 736.00
Volume 54,814
Shares Issued 48.89m
Market Cap £689.35m

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.44% below the market average96.44% below the market average96.44% below the market average96.44% below the market average96.44% below the market average
92% below the sector average92% below the sector average92% below the sector average92% below the sector average92% below the sector average
Price Trend
83.67% above the market average83.67% above the market average83.67% above the market average83.67% above the market average83.67% above the market average
74.19% above the sector average74.19% above the sector average74.19% above the sector average74.19% above the sector average74.19% above the sector average
Income Not Available
Growth
90.91% above the market average90.91% above the market average90.91% above the market average90.91% above the market average90.91% above the market average
88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average

Ergomed Dividends

No dividends found

Trades for 24-Sep-2021

Time Volume / Share Price
16:35 1,392 @ 1,410.00p
16:28 20 @ 1,430.00p
16:28 10 @ 1,430.00p
16:14 29 @ 1,430.00p
16:14 25 @ 1,430.00p

Ergomed Key Personnel

CFO Richard Barfield

Top of Page